Airsonett AB

medical devices

About

Airsonett is a Swedish medical device company that leads the way in the development of non-pharmaceutical treatment of allergic asthma and eczema. We do this by providing Airsonett AIR4, a safe and effective home treatment device that improve health-related quality of life. Main owners are Industrifonden, SEB Venture Capital, Magnus Lundberg and Fåhraeus Startup & Growth. Airsonett has an impressive patent portfolio and has invested heavily in clinical research and product development. Air4 creates a sleep zone that protects you from the exposure to allergens and particles that occur at night and we believe that everyone deserves to breathe perfectly clean air while they sleep. Air4 was initially created for people with severe atopic asthma who, in spite of taking asthma medication, still has poorly controlled asthma. Air4 is recommended by healthcare professionals as an effective at-home treatment for allergic asthma and other allergy induced diseases such as rhinitis and eczema. Using Air4 has no pharmacological side effects and is suitable for both adults and children.

Technologies

Outlook Microsoft Office 365 WordPress.org YouTube Mobile Friendly Google Tag Manager Shutterstock Nginx Circle Remote

Keywords

life science allergy care medtech asthma care atopic dermatitis airflow control airborne allergen removal air quality improvement allergy relief temperature-controlled laminar airflow mdr 2017/745 compliance d2c clinical proven clinical efficacy sustainability non-pharmacologic allergy therapy medical equipment and supplies manufacturing medical device allergy-related disease management eczema treatment respiratory therapy airborne irritants air quality in sleep environment cost-effective home healthcare asthma management healthcare equipment & supplies laminar airflow air filter ce-marked medical device

Location

31 Kelliehousevaegen, Angelholm, Skane County, Sweden, 262 74

Related Companies

Companies in the same industry